These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16448328)

  • 21. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
    Soares CN; Joffe H; Rubens R; Caron J; Roth T; Cohen L
    Obstet Gynecol; 2006 Dec; 108(6):1402-10. PubMed ID: 17138773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of eszopiclone in the treatment of insomnia.
    Morin AK; Willett K
    Adv Ther; 2009 May; 26(5):500-18. PubMed ID: 19513631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eszopiclone (Lunesta), a new hypnotic.
    Med Lett Drugs Ther; 2005 Feb; 47(1203):17-9. PubMed ID: 15767972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
    Boyle J; Trick L; Johnsen S; Roach J; Rubens R
    Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model.
    Botteman MF; Ozminkowski RJ; Wang S; Pashos CL; Schaefer K; Foley DJ
    CNS Drugs; 2007; 21(4):319-34. PubMed ID: 17381185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eszopiclone: an update on its use in insomnia.
    Owen RT
    Drugs Today (Barc); 2011 Apr; 47(4):263-75. PubMed ID: 21573250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zopiclone. An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia.
    Noble S; Langtry HD; Lamb HM
    Drugs; 1998 Feb; 55(2):277-302. PubMed ID: 9506247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression.
    Krystal A; Fava M; Rubens R; Wessel T; Caron J; Wilson P; Roth T; McCall WV
    J Clin Sleep Med; 2007 Feb; 3(1):48-55. PubMed ID: 17557453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo.
    Menza M; Dobkin RD; Marin H; Gara M; Bienfait K; Dicke A; Comella CL; Cantor C; Hyer L
    Mov Disord; 2010 Aug; 25(11):1708-14. PubMed ID: 20589875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial.
    Tek C; Palmese LB; Krystal AD; Srihari VH; DeGeorge PC; Reutenauer EL; Guloksuz S
    Schizophr Res; 2014 Dec; 160(1-3):180-5. PubMed ID: 25454802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eszopiclone (Lunesta) for treatment of transient and chronic insomnia.
    Wessell AM; Weart CW
    Am Fam Physician; 2005 Jun; 71(12):2359-60. PubMed ID: 15999875
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications.
    Greenblatt DJ; Zammit GK
    Expert Opin Drug Metab Toxicol; 2012 Dec; 8(12):1609-18. PubMed ID: 23126273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.
    Pollack MH; Hoge EA; Worthington JJ; Moshier SJ; Wechsler RS; Brandes M; Simon NM
    J Clin Psychiatry; 2011 Jul; 72(7):892-7. PubMed ID: 21367352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults.
    Rosenberg R; Caron J; Roth T; Amato D
    Sleep Med; 2005 Jan; 6(1):15-22. PubMed ID: 15680290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
    Fava M; Schaefer K; Huang H; Wilson A; Iosifescu DV; Mischoulon D; Wessel TC
    J Clin Psychiatry; 2011 Apr; 72(4):473-9. PubMed ID: 21208574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eszopiclone versus zopiclone in the treatment of insomnia.
    Pinto LR; Bittencourt LR; Treptow EC; Braga LR; Tufik S
    Clinics (Sao Paulo); 2016 Jan; 71(1):5-9. PubMed ID: 26872077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain.
    Goforth HW; Preud'homme XA; Krystal AD
    Sleep; 2014 Jun; 37(6):1053-60. PubMed ID: 24882900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of insomnia in elderly patients using eszopiclone.
    Kirkwood C; Breden E
    Nat Sci Sleep; 2010; 2():151-8. PubMed ID: 23616707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial.
    Joffe H; Petrillo L; Viguera A; Koukopoulos A; Silver-Heilman K; Farrell A; Yu G; Silver M; Cohen LS
    Am J Obstet Gynecol; 2010 Feb; 202(2):171.e1-171.e11. PubMed ID: 20035910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.